{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:05:44Z","timestamp":1784286344432,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-07132-w","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T19:00:20Z","timestamp":1780599620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatic steatosis in pediatric obesity: association with cardiometabolic profile and considerations regarding alanine aminotransferase screening"],"prefix":"10.1007","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2794-1719","authenticated-orcid":false,"given":"Aranzazu","family":"Recio Linares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Botija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Bezanilla L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Barasoain Mill\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"del Olmo Segura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"F\u00e9rreo Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidel Cano","family":"Cano Dorao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maritza","family":"Gonzalez-Hoyuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carrero","family":"Carrero \u00c1lvaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais","family":"Garcia Hernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia P\u00e9rez","family":"P\u00e9rez Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"7132_CR1","first-page":"374","volume":"78","author":"J Moran","year":"1983","unstructured":"Moran J, Ghishan F, Halter S et al (1983) Steatohepatitis in obese children: a cause of chronic liver dysfunction. Am J Gastroenterol 78:374\u2013377","journal-title":"Am J Gastroenterol"},{"key":"7132_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","volume":"64","author":"MB Vos","year":"2017","unstructured":"Vos MB, Abrams SH, Barlow SE et al (2017) NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr 64:319\u2013334. https:\/\/doi.org\/10.1097\/MPG.0000000000001482","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"7132_CR3","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J, International Consensus Panel (2020) MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 158:1999\u20132014. https:\/\/doi.org\/10.1053\/j.gastro.2019.11.312","journal-title":"Gastroenterology"},{"key":"7132_CR4","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/S2468-1253(21)00183-7","volume":"6","author":"M Eslam","year":"2021","unstructured":"Eslam M, Alkhouri N, Vajro P et al (2021) Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement. Lancet Gastroenterol Hepatol 6:864\u2013873. https:\/\/doi.org\/10.1016\/S2468-1253(21)00183-7","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"7132_CR5","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V et al (2023) A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78:1966\u20131986. https:\/\/doi.org\/10.1097\/HEP.0000000000000520","journal-title":"Hepatology"},{"key":"7132_CR6","doi-asserted-by":"publisher","unstructured":"European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN); European Association for the Study of the Liver (EASL); North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) et al (2024) Paediatric steatotic liver disease has unique characteristics: a multisociety statement endorsing the new nomenclature. J Pediatr Gastroenterol Nutr 78:1190\u20131196. https:\/\/doi.org\/10.1002\/jpn3.12156","DOI":"10.1002\/jpn3.12156"},{"key":"7132_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00431-024-05848-1","volume":"184","author":"ASR Stroes","year":"2025","unstructured":"Stroes ASR, Vos MB, Benninga MA, Koot BGP et al (2025) Pediatric MASLD: current understanding and practical approach. Eur J Pediatr 184:29. https:\/\/doi.org\/10.1007\/s00431-024-05848-1","journal-title":"Eur J Pediatr"},{"key":"7132_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.obpill.2025.100164","volume":"14","author":"J Panganiban","year":"2025","unstructured":"Panganiban J, Kehar M, Ibrahim SH et al (2025) Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: an Obesity Medicine Association (OMA) and expert joint perspective 2025. Obes Pillars 14:100164. https:\/\/doi.org\/10.1016\/j.obpill.2025.100164","journal-title":"Obes Pillars"},{"key":"7132_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jhep.2023.01.026","volume":"79","author":"AM Allen","year":"2023","unstructured":"Allen AM, Lazarus JV, Younossi ZM et al (2023) Healthcare and socioeconomic costs of NAFLD: a global framework to navigate uncertainties. J Hepatol 79:209\u2013217. https:\/\/doi.org\/10.1016\/j.jhep.2023.01.026","journal-title":"J Hepatol"},{"key":"7132_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140908","volume":"10","author":"EL Anderson","year":"2015","unstructured":"Anderson EL, Howe LD, Jones HE et al (2015) The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis. PLoS ONE 10:e0140908. https:\/\/doi.org\/10.1371\/journal.pone.0140908","journal-title":"PLoS ONE"},{"key":"7132_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0032-1306421","volume":"32","author":"DE Kleiner","year":"2012","unstructured":"Kleiner DE, Brunt EM (2012) Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research. Semin Liver Dis 32:3\u201313. https:\/\/doi.org\/10.1055\/s-0032-1306421","journal-title":"Semin Liver Dis"},{"key":"7132_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/MPG.0b013e31821b4b61","volume":"53","author":"A Shannon","year":"2011","unstructured":"Shannon A, Alkhouri N, Carter-Kent C et al (2011) Ultrasonographic quantitative estimation of hepatic steatosis in children with NALFD. J Pediatr Gastroenterol Nutr 53:190\u2013195. https:\/\/doi.org\/10.1097\/MPG.0b013e31821b4b61","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"7132_CR13","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1002\/hep.27666","volume":"61","author":"JB Schwimmer","year":"2015","unstructured":"Schwimmer JB, Middleton MS, Behling C et al (2015) Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease. Hepatology 61:1887\u20131895. https:\/\/doi.org\/10.1002\/hep.27666","journal-title":"Hepatology"},{"key":"7132_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.784221","volume":"9","author":"S Jia","year":"2022","unstructured":"Jia S, Zhao Y, Liu J et al (2022) Magnetic resonance imaging-proton density fat fraction vs. transient elastography-controlled attenuation parameter in diagnosing non-alcoholic fatty liver disease in children and adolescents: a meta-analysis of diagnostic accuracy. Front Pediatr 9:784221. https:\/\/doi.org\/10.3389\/fped.2021.784221","journal-title":"Front Pediatr"},{"key":"7132_CR15","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1002\/hep4.1983","volume":"6","author":"A Chaidez","year":"2022","unstructured":"Chaidez A, Pan Z, Sundaram SS et al (2022) The discriminatory ability of FibroScan liver stiffness measurement, controlled attenuation parameter, and FibroScan-aspartate aminotransferase to predict severity of liver disease in children. Hepatol Commun 6:3015\u20133023. https:\/\/doi.org\/10.1002\/hep4.1983","journal-title":"Hepatol Commun"},{"key":"7132_CR16","doi-asserted-by":"publisher","first-page":"996","DOI":"10.2214\/AJR.20.24874","volume":"217","author":"A D\u2019hondt","year":"2021","unstructured":"D\u2019hondt A, Rubesova E, Xie H et al (2021) Liver fat quantification by ultrasound in children: a prospective study. AJR Am J Roentgenol 217:996\u20131006. https:\/\/doi.org\/10.2214\/AJR.20.24874","journal-title":"AJR Am J Roentgenol"},{"key":"7132_CR17","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.ultrasmedbio.2022.02.005","volume":"48","author":"H Yoon","year":"2022","unstructured":"Yoon H, Kim J, Lim HJ et al (2022) Attenuation coefficient measurement using a high-frequency (2\u20139 MHz) convex transducer for children including fatty liver. Ultrasound Med Biol 48:1070\u20131077. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2022.02.005","journal-title":"Ultrasound Med Biol"},{"key":"7132_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/biology11071087","volume":"11","author":"K Song","year":"2022","unstructured":"Song K, Son NH, Chang DR et al (2022) Feasibility of ultrasound attenuation imaging for assessing pediatric hepatic steatosis. Biology 11:1087. https:\/\/doi.org\/10.3390\/biology11071087","journal-title":"Biology"},{"key":"7132_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-025-04540-w","author":"L Lahtinen","year":"2025","unstructured":"Lahtinen L, Hiltunen P, Vuorela N et al (2025) Screening and diagnosis of metabolic dysfunction-associated steatotic liver disease in children within public healthcare. Pediatr Res. https:\/\/doi.org\/10.1038\/s41390-025-04540-w","journal-title":"Pediatr Res"},{"key":"7132_CR20","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1097\/MPG.0b013e318252a13f","volume":"55","author":"P Vajro","year":"2012","unstructured":"Vajro P, Lenta S, Socha P et al (2012) Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr 55:700\u2013713. https:\/\/doi.org\/10.1097\/MPG.0b013e318252a13f","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"7132_CR21","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1053\/j.gastro.2009.12.052","volume":"138","author":"JB Schwimmer","year":"2010","unstructured":"Schwimmer JB, Dunn W, Norman GJ et al (2010) SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology 138:1357-1364.e13642. https:\/\/doi.org\/10.1053\/j.gastro.2009.12.052","journal-title":"Gastroenterology"},{"key":"7132_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2021.101755","volume":"46","author":"BR Chen","year":"2022","unstructured":"Chen BR, Pan CQ (2022) Non-invasive assessment of fibrosis and steatosis in pediatric non-alcoholic fatty liver disease. Clin Res Hepatol Gastroenterol 46:101755. https:\/\/doi.org\/10.1016\/j.clinre.2021.101755","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"7132_CR23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jpeds.2021.09.033","volume":"240","author":"SJ Wu","year":"2022","unstructured":"Wu SJ, Darbinian JA, Schwimmer JB et al (2022) The prevalence of elevated alanine aminotransferase levels meeting clinical action thresholds in children with obesity in primary care practice. J Pediatr 240:280\u2013283. https:\/\/doi.org\/10.1016\/j.jpeds.2021.09.033","journal-title":"J Pediatr"},{"key":"7132_CR24","volume-title":"Growth curves and tables: longitudinal and cross-sectional studies","author":"B Sobradillo","year":"2004","unstructured":"Sobradillo B, Aguirre A, Aresti U et al (2004) Growth curves and tables: longitudinal and cross-sectional studies. Fundaci\u00f3n Faustino Orbegozo Eizaguirre, Bilbao, Spain"},{"key":"7132_CR25","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1542\/peds.114.S2.555","volume":"114","author":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents","year":"2004","unstructured":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555\u2013576","journal-title":"Pediatrics"},{"key":"7132_CR26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/sj.ejcn.1600769","volume":"53","author":"LA Moreno","year":"1999","unstructured":"Moreno LA, Fleta J, Mur L et al (1999) Waist circumference values in Spanish children\u2013gender-related differences. Eur J Clin Nutr 53:429\u2013433. https:\/\/doi.org\/10.1038\/sj.ejcn.1600769","journal-title":"Eur J Clin Nutr"},{"key":"7132_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1399-5448.2007.00271.x","volume":"8","author":"P Zimmet","year":"2007","unstructured":"Zimmet P, Alberti KG, Kaufman F et al (2007) The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 8:299\u2013306. https:\/\/doi.org\/10.1111\/j.1399-5448.2007.00271.x","journal-title":"Pediatr Diabetes"},{"key":"7132_CR28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12887-021-02595-2","volume":"21","author":"L Peng","year":"2021","unstructured":"Peng L, Wu S, Zhou N et al (2021) Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity. BMC Pediatr 21:122. https:\/\/doi.org\/10.1186\/s12887-021-02595-2","journal-title":"BMC Pediatr"},{"key":"7132_CR29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S1875-9572(10)60028-9","volume":"51","author":"YC Lin","year":"2010","unstructured":"Lin YC, Chang PF, Yeh SJ et al (2010) Risk factors for liver steatosis in obese children and adolescents. Pediatr Neonatol 51:149\u2013154. https:\/\/doi.org\/10.1016\/S1875-9572(10)60028-9","journal-title":"Pediatr Neonatol"},{"key":"7132_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4103\/jfcm.JFCM_287_19","volume":"27","author":"N Gupta","year":"2020","unstructured":"Gupta N, Jindal G, Nadda A et al (2020) Prevalence and risk factors for nonalcoholic fatty liver disease in obese children in rural Punjab, India. J Family Community Med 27:103\u2013108. https:\/\/doi.org\/10.4103\/jfcm.JFCM_287_19","journal-title":"J Family Community Med"},{"key":"7132_CR31","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014939","volume":"98","author":"K Zhao","year":"2019","unstructured":"Zhao K, Ju H, Wang H (2019) Metabolic characteristics of obese children with fatty liver: a STROBE-compliant article. Medicine (Baltimore) 98:e14939. https:\/\/doi.org\/10.1097\/MD.0000000000014939","journal-title":"Medicine (Baltimore)"},{"key":"7132_CR32","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/MPG.0b013e3182185ac4","volume":"53","author":"A Ruiz-Extremera","year":"2011","unstructured":"Ruiz-Extremera A, Carazo \u00c1, Salmer\u00f3n \u00c1 et al (2011) Factors associated with hepatic steatosis in obese children and adolescents. J Pediatr Gastroenterol Nutr 53:196\u2013201. https:\/\/doi.org\/10.1097\/MPG.0b013e3182185ac4","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"7132_CR33","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1161\/CIRCULATIONAHA.107.739920","volume":"118","author":"JB Schwimmer","year":"2008","unstructured":"Schwimmer JB, Pardee PE, Lavine JE et al (2008) Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation 118:277\u2013283. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.739920","journal-title":"Circulation"},{"key":"7132_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/cob.12502","volume":"12","author":"RR Putri","year":"2022","unstructured":"Putri RR, Caswall T, Hagman E (2022) Risk and protective factors of non-alcoholic fatty liver disease in paediatric obesity: a nationwide nested case\u2013control study. Clin Obes 12:e12502. https:\/\/doi.org\/10.1111\/cob.12502","journal-title":"Clin Obes"},{"key":"7132_CR35","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12887-019-1711-4","volume":"19","author":"S Greber-Platzer","year":"2019","unstructured":"Greber-Platzer S, Thajer A, Bohn S et al (2019) Increased liver echogenicity and liver enzymes are associated with extreme obesity, adolescent age and male gender: analysis from the German\/Austrian\/Swiss obesity registry APV. BMC Pediatr 19:332. https:\/\/doi.org\/10.1186\/s12887-019-1711-4","journal-title":"BMC Pediatr"},{"key":"7132_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.992264","volume":"13","author":"K Marcinkiewicz","year":"2022","unstructured":"Marcinkiewicz K, Horodnicka-J\u00f3zwa A, Jackowski T et al (2022) Nonalcoholic fatty liver disease in children with obesity \u2013 observations from one clinical centre in the Western Pomerania region. Front Endocrinol (Lausanne) 13:992264. https:\/\/doi.org\/10.3389\/fendo.2022.992264","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7132_CR37","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00431-019-03362-3","volume":"178","author":"LG Draijer","year":"2019","unstructured":"Draijer LG, Feddouli S, Bohte AE et al (2019) Comparison of diagnostic accuracy of screening tests ALT and ultrasound for pediatric non-alcoholic fatty liver disease. Eur J Pediatr 178:863\u2013870. https:\/\/doi.org\/10.1007\/s00431-019-03362-3","journal-title":"Eur J Pediatr"},{"key":"7132_CR38","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jhepr.2019.06.005","volume":"1","author":"Y Ezaizi","year":"2019","unstructured":"Ezaizi Y, Kabbany MN, Selvakumar CPK et al (2019) Comparison between non-alcoholic fatty liver disease screening guidelines in children and adolescents. JHEP Rep 1:259\u2013264. https:\/\/doi.org\/10.1016\/j.jhepr.2019.06.005","journal-title":"JHEP Rep"},{"key":"7132_CR39","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/apt.12518","volume":"38","author":"JB Schwimmer","year":"2013","unstructured":"Schwimmer JB, Newton KP, Awai HI et al (2013) Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease. Aliment Pharmacol Ther 38:1267\u20131277","journal-title":"Aliment Pharmacol Ther"},{"key":"7132_CR40","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.cgh.2025.05.011","volume":"24","author":"ASR Stroes","year":"2026","unstructured":"Stroes ASR, Draijer L, Chegary M et al (2026) ALT is an effective screening tool for advanced metabolic dysfunction-associated steatotic liver disease in children with obesity and overweight. Clin Gastroenterol Hepatol 24:385\u2013393. https:\/\/doi.org\/10.1016\/j.cgh.2025.05.011","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07132-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07132-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07132-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T10:26:18Z","timestamp":1784283978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-07132-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["7132"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07132-w","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"4 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Clinical Research Ethics Committee of Hospital Universitario Fundaci\u00f3n de Alcorc\u00f3n (approval number: 23\/102). All procedures were performed in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments. Informed consent was obtained from the children\u2019s parents or guardians before enrolment.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"468"}}